| Francisco Rafael Oquendo, MD | |
|
1140 S Semoran Blvd, Suite E, Orlando, FL 32807-1459 | |
| (407) 384-9165 | |
| (407) 384-9174 |
| Full Name | Francisco Rafael Oquendo |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 1140 S Semoran Blvd, Orlando, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124107255 | NPI | - | NPPES |
| 013950700 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 15967 (Puerto Rico) | Secondary |
| 207Q00000X | Family Medicine | ACN598 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pcc Medical Holdings Llc | 0446679468 | 29 |
News Archive
GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.
The regular use of aspirin lowers the risk for pancreatic cancer by almost 50 percent, a new study in China led by the Yale School of Public Health finds.
Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.
Hundreds of thousands of Vietnam War veterans are receiving disability compensation for diseases normally associated with aging - not combat - because of the possibility of a link Agent Orange exposure. The diseases in question range from diabetes, for which 270,000 veterans receive Agent Orange-related checks, to erectile dysfunction.
US Oncology, Inc., the nation's leading integrated oncology company, announced today that in less than two decades it has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration.
› Verified 7 days ago
| Entity Name | Pcc Medical Holdings Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174167993 PECOS PAC ID: 0446679468 Enrollment ID: O20200924001757 |
News Archive
GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.
The regular use of aspirin lowers the risk for pancreatic cancer by almost 50 percent, a new study in China led by the Yale School of Public Health finds.
Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.
Hundreds of thousands of Vietnam War veterans are receiving disability compensation for diseases normally associated with aging - not combat - because of the possibility of a link Agent Orange exposure. The diseases in question range from diabetes, for which 270,000 veterans receive Agent Orange-related checks, to erectile dysfunction.
US Oncology, Inc., the nation's leading integrated oncology company, announced today that in less than two decades it has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Francisco Rafael Oquendo, MD 1140 S Semoran Blvd, Suite E, Orlando, FL 32807-1459 Ph: (407) 384-9165 | Francisco Rafael Oquendo, MD 1140 S Semoran Blvd, Suite E, Orlando, FL 32807-1459 Ph: (407) 384-9165 |
News Archive
GE Healthcare, a unit of General Electric Company, today announced that DaTSCAN (ioflupane I 123 injection), a radiopharmaceutical agent intended for use with single photon emission computed tomography (SPECT) imaging of the brain, has been recommended in updated European Federation of the Neurological Societies (EFNS) guidelines for the diagnosis and management of Alzheimer's disease (AD). The guidelines appear in the October issue of the European Journal of Neurology.
The regular use of aspirin lowers the risk for pancreatic cancer by almost 50 percent, a new study in China led by the Yale School of Public Health finds.
Concert Pharmaceuticals, Inc. today announced that it has initiated a Phase 1 clinical trial with CTP-354. CTP-354 is a novel GABAA receptor subtype-selective modulator that has demonstrated no sedation at therapeutic doses in preclinical models in contrast to existing GABAA receptor non-selective agonists, such as benzodiazepines.
Hundreds of thousands of Vietnam War veterans are receiving disability compensation for diseases normally associated with aging - not combat - because of the possibility of a link Agent Orange exposure. The diseases in question range from diabetes, for which 270,000 veterans receive Agent Orange-related checks, to erectile dysfunction.
US Oncology, Inc., the nation's leading integrated oncology company, announced today that in less than two decades it has played a role in the development of 42 novel cancer therapies approved by the US Food and Drug Administration.
› Verified 7 days ago
Diana Jaime, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 942 Lake Baldwin Ln, Orlando, FL 32814 Phone: 407-895-8059 | |
Richard Luke Elloway, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 7751 Kingspointe Pkwy Ste 114, Orlando, FL 32819 Phone: 407-581-9672 Fax: 407-581-9673 | |
Dr. Cristina P Garcia, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2863 S Delaney Ave, Orlando, FL 32806 Phone: 407-843-1620 Fax: 407-843-5243 | |
Dr. Sandra Ivelisse Alvarez, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 13800 Veterans Way, Hero Clinic 1f, Orlando, FL 32827 Phone: 407-631-1000 | |
Tayyaba Nadir Tariq, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6320 Old Winter Garden Rd, Orlando, FL 32835 Phone: 407-290-0555 Fax: 407-295-0028 | |
Dr. Christopher Patrick Carroll, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 9400 Turkey Lake Rd, Orlando, FL 32819 Phone: 321-843-5500 Fax: 321-843-5550 | |
Dr. Keith Allan Campbell, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11221 John Wycliffe Blvd, Orlando, FL 32832 Phone: 407-852-3880 Fax: 407-852-3881 |